Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT04737928 Completed - Clinical trials for Glaucoma, Primary Open Angle

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

Start date: April 2, 2018
Phase: N/A
Study type: Interventional

The objective of this study was to investigate the improving effect of corneal disorder in primary open-angle glaucoma and ocular hypertension patients, when switched from the 0.005% latanoprost ophthalmic solution (one drop at a time, once daily) to the 0.0015% tafluprost ophthalmic solution (one drop at a time, once daily). Efficacy also was investigated.

NCT ID: NCT04726761 Completed - Hypertension Clinical Trials

Frequent Cuff Inflations May Disrupt the Accuracy of 24-hour Ambulatory Blood Pressure Monitoring

Start date: March 2, 2021
Phase:
Study type: Observational

24-hour ambulatory blood pressure monitoring (ABPM) is superior to office blood pressure (BP) for assessing cardiovascular risk. On the other hand, repeated cuff inflations during ABPM can cause discomfort and reduced quality of sleep. A high frequency of measurement during ABPM might result in erroneously high BP measurement, incorrect hypertension diagnoses, unnecessary treatment or just overtreatment with antihypertensive medication and potentially serious side effects. The purpose of this study is to investigate whether the frequency of measurements during ABPM impacts the measured BP during ABPM. Patients will be recruited from the Clinic of Hypertension at Aarhus University Hospital, Denmark. The study will be conducted as a randomized controlled crossover study. Participants will undergo two 24-hour ABPMs: One with a low frequency of measurement, 1-time per hour during the day and 1-time per hour during the night, and one with a high frequency, 3-times/hour during the day, and 2-times/hour at night. The primary endpoint will be the difference in 24-hour mean systolic BP between the high- and low frequency measurement ABPM.

NCT ID: NCT04715698 Completed - Hypertension Clinical Trials

Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control

Start date: December 31, 2018
Phase: N/A
Study type: Interventional

A single-center, single-blind, randomized study to investigate the effectiveness of a hemodynamic-guided treatment strategy to improve blood pressure control

NCT ID: NCT04715113 Completed - Clinical trials for Hypertension, Pulmonary

Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension

HEXABM
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To study the effect of acute normobaric hypoxia during exercise in patients with pulmonary hypertension on blood markers (serum markers of iron and red blood cell homeostasis and micro-RNAs known to be associated with PH).

NCT ID: NCT04714398 Completed - Hypertension Clinical Trials

SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management

Start date: February 26, 2021
Phase: N/A
Study type: Interventional

A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).

NCT ID: NCT04714320 Completed - Hypertension Clinical Trials

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

ASTRAAS
Start date: March 4, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of IONIS-AGT-LRx compared to placebo on seated automated office systolic blood pressure (SBP) from baseline to Study Day 85 in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications and to evaluate the effect of IONIS-AGT-LRx on ambulatory blood pressure, seated automated office SBP, seated automated office diastolic blood pressure (DBP), and plasma angiotensinogen (AGT) at each scheduled visit in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications.

NCT ID: NCT04712669 Completed - Clinical trials for Pulmonary Arterial Hypertension

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2)

Start date: March 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of Rodatristat Ethyl in pulmonary arterial hypertension (PAH) patients.

NCT ID: NCT04706546 Completed - Clinical trials for Hypertension, Pulmonary

Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil

HEXASN
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To study hemodynamic effects of Sildenafil during exercise in patients with pulmonary hypertension.

NCT ID: NCT04704440 Completed - Clinical trials for Hypertension, Pulmonary

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil

HEXAS
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To study the effect of acute normobaric hypoxia during exercise in patients with pulmonary hypertension with/without Sildenafil

NCT ID: NCT04697875 Completed - Clinical trials for Hypertension, Pulmonary

Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension

HEXA
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To study hemodynamic effects of acute normobaric hypoxia during exercise in patients with pulmonary hypertension in a single-center randomized controlled trial.